MINI REVIEW article
Front. Neurol.
Sec. Neuromuscular Disorders and Peripheral Neuropathies
Volume 16 - 2025 | doi: 10.3389/fneur.2025.1678151
Ocular Myasthenia Gravis Management
Provisionally accepted- 1Icahn School of Medicine at Mount Sinai, New York, United States
- 2University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, United States
- 3The George Washington University Department of Neurology, Washington, United States
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Ocular myasthenia gravis (OMG) has no agreed upon diagnostic and management criteria, leading to misdiagnoses and often misguided treatments. The purpose of this minireview is to provide guidance to clinicians who encounter possible OMG patients. We cite relevant literature and the recommendations for diagnosis and therapy based on the authors' extensive experience in OMG. This report provides sound recommendations based on the authors' successes and failures coupled with relevant literature in the myasthenia gravis field.
Keywords: Ocular myasthenia gravis, myasthenia gravis diagnosis, myasthenia gravis treatment, OMG mimics, OMG
Received: 01 Aug 2025; Accepted: 16 Oct 2025.
Copyright: © 2025 Kupersmith, Wolfe and Kaminski. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Mark Kupersmith, mark.kupersmith@mountsinai.org
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.